Maintelyte

Magnesium chloride hexahydrate, potassium chloride, sodium chloride, glucose, and sodium acetate trihydrate, the active ingredients in Maintelyte, are an electrolyte solution presented as a sterile solution for injection for intravenous use. It restores electrolyte balance and provides fluid volume in patients requiring electrolyte replacement or fluid resuscitation.

GNH USA supplies Maintelyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, and clinics worldwide.

Maintelyte is used to address disorders of fluid and electrolyte balance. - Electrolyte replacement: restores normal plasma concentrations of magnesium, potassium, sodium, and chloride. - Fluid resuscitation: provides necessary intravascular volume in patients with hypovolemia. - Hypomagnesemia: corrects low magnesium levels in acute or chronic deficiency. - Hypokalemia: replenishes potassium stores in patients with low serum potassium.

Intravenous administration of Maintelyte may be associated with the following adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Hypernatremia: elevated serum sodium if administered excessively. - Hyperkalemia: increased serum potassium levels in susceptible patients. - Hypermagnesemia: elevated magnesium concentrations with high doses.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate treatment. - Electrolyte imbalance: severe disturbances leading to cardiac arrhythmias. - Fluid overload: pulmonary edema in patients with compromised cardiac function. - Metabolic acidosis: rare shift due to acetate metabolism.

When using Maintelyte, consider the following precautions to ensure safe administration. - Assess electrolyte levels: measure serum magnesium, potassium, and sodium before infusion. - Adjust infusion rate: tailor speed according to patient’s volume status and cardiac function. - Monitor cardiac rhythm: continuous ECG monitoring in patients at risk of arrhythmia. - Use caution in renal impairment: reduced excretion may lead to accumulation of electrolytes. - Avoid in severe hypermagnesemia or hyperkalemia: contraindicated when serum levels are already high. - Store below 25°C: keep in original container, protect from moisture and direct light.

Maintelyte can interact with certain medications; awareness of these interactions helps prevent complications.

Major Interactions (Avoid): - Calcium channel blockers: concurrent use may potentiate hypermagnesemia. - Digoxin: elevated potassium can increase risk of digoxin toxicity. - ACE inhibitors or ARBs: may exacerbate hyperkalemia when combined.

Moderate Interactions (Monitor Closely): - Loop diuretics: may require adjustment of electrolyte replacement dose. - Insulin therapy: glucose content can affect blood sugar; monitor glycemia. - Antacids containing magnesium or aluminum: additive electrolyte load may lead to imbalance.